Tan, A. C., Liao, B., Li, M. S., Lee, D. D., Uehara, Y., Thamlikitkul, L., Zhang, J., Kim, D., Mok, T. S., Tan, D. S., Wu, Y., Ahn, M. (2026). Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC: A Delphi study by the Asian Thoracic Oncology Research Group (ATORG).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.289